A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers ...

Vertex Pharmaceuticals is set to report its first-quarter results next month, and analysts are expecting high single-digit ...

In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a ...

The expanded approval was based on clinical and/or in vitro data demonstrating responsiveness across 564 variants for Alyftrek and 521 variants for Trikafta. The label expansions were granted based on ...

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of ...

The agency has expanded the use of Alyftrek and Trikafta for treating patients with any genetic variant that results in production of CFTR proteins.

IOC introduces gene-screening test for female category eligibility New rules stop transgender athletes competing in female category events Exceptions for rare sex development disorders like CAIS ...

In 1976, Richard Dawkins published a book titled after an idea he’d come up with while teaching a lecture on animal behaviour for his PhD supervisor. It just so happened that the idea of The Selfish ...